1. Home
  2. CRDF vs OZ Comparison

CRDF vs OZ Comparison

Compare CRDF & OZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRDF
  • OZ
  • Stock Information
  • Founded
  • CRDF 1999
  • OZ 2020
  • Country
  • CRDF United States
  • OZ United States
  • Employees
  • CRDF N/A
  • OZ N/A
  • Industry
  • CRDF Biotechnology: Biological Products (No Diagnostic Substances)
  • OZ
  • Sector
  • CRDF Health Care
  • OZ
  • Exchange
  • CRDF Nasdaq
  • OZ Nasdaq
  • Market Cap
  • CRDF 240.2M
  • OZ 224.7M
  • IPO Year
  • CRDF N/A
  • OZ N/A
  • Fundamental
  • Price
  • CRDF $3.45
  • OZ $60.75
  • Analyst Decision
  • CRDF Strong Buy
  • OZ
  • Analyst Count
  • CRDF 3
  • OZ 0
  • Target Price
  • CRDF $10.33
  • OZ N/A
  • AVG Volume (30 Days)
  • CRDF 1.4M
  • OZ 16.7K
  • Earning Date
  • CRDF 02-27-2025
  • OZ 01-01-0001
  • Dividend Yield
  • CRDF N/A
  • OZ N/A
  • EPS Growth
  • CRDF N/A
  • OZ N/A
  • EPS
  • CRDF N/A
  • OZ N/A
  • Revenue
  • CRDF $688,000.00
  • OZ $2,092,000.00
  • Revenue This Year
  • CRDF $25.03
  • OZ N/A
  • Revenue Next Year
  • CRDF N/A
  • OZ N/A
  • P/E Ratio
  • CRDF N/A
  • OZ N/A
  • Revenue Growth
  • CRDF 49.57
  • OZ N/A
  • 52 Week Low
  • CRDF $1.44
  • OZ $42.75
  • 52 Week High
  • CRDF $6.42
  • OZ $80.88
  • Technical
  • Relative Strength Index (RSI)
  • CRDF 45.05
  • OZ 26.63
  • Support Level
  • CRDF $3.33
  • OZ $60.00
  • Resistance Level
  • CRDF $4.89
  • OZ $64.02
  • Average True Range (ATR)
  • CRDF 0.31
  • OZ 2.75
  • MACD
  • CRDF -0.15
  • OZ -1.41
  • Stochastic Oscillator
  • CRDF 10.56
  • OZ 4.30

About CRDF Cardiff Oncology Inc.

Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").

About OZ Belpointe PREP LLC Units

Belpointe PREP LLC is a qualified opportunity fund. The company's investments consist of properties located in qualified opportunity zones for the development or redevelopment of multifamily, student housing, senior living, healthcare, industrial, self-storage, hospitality, office, mixed-use, data centers, and solar projects located throughout the United States and its territories.

Share on Social Networks: